A random drawing: That’s how the Washington State Liquor Control Board proposes choosing applicants for marijuana retail licenses. And it’s drawing major criticism from existing medical marijuana providers.
Two weeks ago the federal Drug Enforcement Administration sent cease and desist letters to 11 medical marijuana dispensaries in Seattle. It was the first notable enforcement action in Washington since recreational marijuana was legalized last year. Federal officials say it won’t be the last.
For answers, KUOW’s Steve Scher talked with Thomas McLellan, Ph.D. He’s CEO and co-founder of the Treatment Research Institute, and is an internationally known substance abuse researcher and public policy expert. Most recently, he served as deputy director of the White House Office of National Drug Control Policy under the Obama-Biden administration, where he was heavily involved in health care reform.